[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.129.96. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Capitol Health Call
February 11, 2004

NIH Panel Examines Conflicts

JAMA. 2004;291(6):684. doi:10.1001/jama.291.6.684-a

In response to criticism and Congressional inquiries, National Institutes of Health (NIH) Director Elias Zerhouni, MD, announced the creation of a "blue ribbon" panel to examine the agency's rules governing financial conflicts of interest. The panel is to examine all applicable laws and regulations and hand recommendations to Zerhouni within 90 days.

The controversy over conflicts of interest began December 7, when The Los Angeles Times reported that top NIH officials, including several institute directors, had collected millions of dollars in consulting fees from pharmaceutical companies. House and Senate hearings on the matter are scheduled.

First Page Preview View Large
First page PDF preview
First page PDF preview
×